AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 22983593
Drug: Atropine 10
RxNorm normalized name: Isopto Atropine 10 MG/ML Ophthalmic Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine 10 μg/kg
Trial: 21429067
Drug: Prostaglandin E2
RxNorm normalized name: Prostaglandin E2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prostaglandin E2 vaginal gel (1 mg/2 mg)
Trial: 21429067
Drug: Prostaglandin E2
RxNorm normalized name: Prostaglandin E2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prostaglandin E2 vaginal tablets (3 mg)
Trial: 16944044
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) replacement therapy for 24 months
Trial: 12738139
Drug: Metronidazole (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole (250 mg orally three times per day) and erythromycin (250 mg orally four times per day) for 10 days
Trial: 12738139
Drug: Placebo pills
RxNorm normalized name: placebo Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo pills for 10 days
Trial: 9071898
Drug: Multimodal therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multimodal therapy (pre‐operative chemotherapy, Patey mastectomy, flap irradiation and adjuvant hormone therapy)
Trial: 8416161
Drug: Tolrestat (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolrestat (200 mg/d given in the morning)
Trial: 21135170
Drug: Oral glucocorticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral glucocorticosteroids (GCSs)
Trial: 21135170
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of anti-TGF-β and anti-IL-10 Abs
Trial: 18973494
Drug: Early losartan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early losartan therapy
Trial: 18973494
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no losartan therapy)
Trial: 17165637
Drug: ezetimibe/simvastatin, 10/20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ezetimibe/simvastatin, 10/20 mg/d
Trial: 17165637
Drug: ezetimibe/simvastatin, 10/40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ezetimibe/simvastatin, 10/40 mg/d
Trial: 7761882
Drug: loratadine 10mg
RxNorm normalized name: LORATADINE 10MG TAB
DrugBank: Loratadine (DB00455)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: loratadine 10mg daily
Trial: 7761882
Drug: astemizole 10mg
RxNorm normalized name: ASTEMIZOLE 10MG TAB
DrugBank: Astemizole (DB00637)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: astemizole 10mg daily
Trial: 3287943
Drug: SCH 33861
RxNorm normalized name: SCH 58500
DrugBank: SCH-58500 (DB17416)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCH 33861 (topical angiotensin converting enzyme inhibitor)
Trial: 19738134
Drug: Accelerated infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Accelerated infusion of streptokinase
Trial: 19738134
Drug: Conventional infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional infusion of streptokinase
Trial: 23316063
Drug: 10 mM
RxNorm normalized name: potassium 10 MMOL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mM N(G)-nitro-l-arginine methyl ester (l-NAME; NO synthase inhibitor)
Trial: 23316063
Drug: 10 mM
RxNorm normalized name: potassium 10 MMOL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mM ketorolac (COX inhibitor)
Trial: 23316063
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of l-NAME + ketorolac
Trial: 21077801
Drug: Low-dose prednisolone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose prednisolone (5-7.5 mg) for at least 2 years (P-group)
Trial: 21077801
Drug: No prednisolone
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No prednisolone treatment (NoP-group)
Trial: 19808874
Drug: Ipilimumab at
RxNorm normalized name: Ipilimumab
DrugBank: Ipilimumab (DB06186)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ipilimumab at 3 mg/kg and then monthly at 1 mg/kg x 3 months (dose level 1), escalating to 3 mg/kg monthly x 4 months (dose level 2)
Trial: 16739319
Drug: Intraarterial ACNU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraarterial ACNU administration (17 patients)
Trial: 16739319
Drug: Intravenous ACNU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ACNU administration (16 patients)
Trial: 14715359
Drug: High-dose nitroglycerin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose nitroglycerin
Trial: 7798535
Drug: Inhaled beclomethasone
RxNorm normalized name: beclomethasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled beclomethasone dipropionate 500 micrograms twice a day
Trial: 3277875
Drug: Prostaglandin E2
RxNorm normalized name: Prostaglandin E2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prostaglandin E2 vaginal suppositories (2.5 mg PGE2 in Witepsol S55)
Trial: 3277875
Drug: Intracervical prostaglandin
RxNorm normalized name: Prostaglandin D2
DrugBank: Prostaglandin D2 (DB02056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracervical prostaglandin gel (1 mg PGE2 in 5 g hydroxypropylmethyl cellulose)
Trial: 3277875
Drug: Intracervical prostaglandin
RxNorm normalized name: Prostaglandin D2
DrugBank: Prostaglandin D2 (DB02056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracervical prostaglandin gel
Trial: 29678471
Drug: Radium-223 (Ra-223)
RxNorm normalized name: Radium Ra-223
DrugBank: Radium Ra-223 (DB12813)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radium-223 (Ra-223) therapy
Trial: 11014375
Drug: Vasodilator therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vasodilator therapy in chronic aortic regurgitation (AR)
Trial: 11014375
Drug: Vasodilator therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vasodilator therapy in chronic mitral regurgitation (MR)
Trial: 11014375
Drug: Vasodilator therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vasodilator therapy in mitral valve prolapse or hypertrophic cardiomyopathy
Trial: 11014375
Drug: Vasodilator therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vasodilator therapy in other primary causes of MR
Trial: 30702758
Drug: Culturally adapted
RxNorm normalized name: casein, emmental cultured
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Culturally adapted guided internet‐based cognitive behavior therapy (ICBT) for 8 weeks
Trial: 30446003
Drug: Screening trial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Screening trial prior to SCS implant
Trial: 26415549
Drug: Temoporfin photodynamic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temoporfin photodynamic therapy (PDT) plus chemotherapy and stent
Trial: 26415549
Drug: Chemotherapy and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy and stent without temoporfin PDT
Trial: 15295370
Drug: Foley catheter
RxNorm normalized name: Bard Foley Catheter 18FR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Foley catheter with extra-amniotic saline infusion (EASI)
Trial: 29930229
Drug: Mindfulness-Based Stress
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mindfulness-Based Stress Reduction (MBSR) therapy
Trial: 20959284
Drug: Titrated oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Titrated oxygen treatment
Trial: 20959284
Drug: High flow
RxNorm normalized name: Blood Set High Flow
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High flow oxygen treatment
Trial: 18238963
Drug: Transdermal contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal contraceptive (0.75 mg ethinyl estradiol and 6 mg norelgestromin)
Trial: 18238963
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive (35 mcg ethinyl estradiol and 250 mcg norgestimate)
Trial: 18238963
Drug: Transdermal contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal contraceptive
Trial: 16792583
Drug: drugs +
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: drugs + placebo
Trial: 14624409
Drug: alpha-blockade (prazosin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alpha-blockade (prazosin 3 mg/d)
Trial: 11053072
Drug: Ciprofloxacin 500
RxNorm normalized name: ciprofloxacin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 500 mg twice daily orally for three months
Trial: 8932352
Drug: Early alternating
RxNorm normalized name: yellow fever virus strain 17D-204 live antigen
DrugBank: Yellow fever vaccine (DB10805)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early alternating chemotherapy
Trial: 8932352
Drug: Late alternating
RxNorm normalized name: yellow fever virus strain 17D-204 live antigen
DrugBank: Yellow fever vaccine (DB10805)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Late alternating chemotherapy
Trial: 1434266
Drug: Adjuvant combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant combination chemotherapy including cis‐platinum
Trial: 1434266
Drug: Adjuvant combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant combination chemotherapy including cis‐platinum with 3 or more cycles
Trial: 1434266
Drug: Pre‐operative treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre‐operative treatment such as irradiation and intra‐arterial chemotherapy
Trial: 12269263
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy (general)
Trial: 3904322
Drug: Metoprolol-hydralazine treatment
RxNorm normalized name: hydralazine / hydrochlorothiazide / metoprolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol-hydralazine treatment
Trial: 29277158
Drug: Symbiotic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Symbiotic treatment (Lactobacillus paracasei, L. rhamnosus, L. acidophilus, Bifidobacterium lactis plus 6 g of fructo‐oligosaccharides)
Trial: 29277158
Drug: Control (placebo:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (placebo: 6 g of maltodextrin)
Trial: 29277158
Drug: Symbiotic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Symbiotic treatment
Trial: 26038091
Drug: 750 mg
RxNorm normalized name: bran 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 mg intravenous rontalizumab every 4 weeks
Trial: 26038091
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg subcutaneous rontalizumab every 2 weeks
Trial: 24190613
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg sildenafil per day for 12 weeks
Trial: 22894176
Drug: Migraine Group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Migraine Group (MG)
Trial: 20571436
Drug: Extra methadone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extra methadone (50% extra dose on top of prescribed daily dosage)
Trial: 16380486
Drug: Lipid infusion
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid infusion (LIP) with plasma FFA approximately 1,034 micromol/l
Trial: 16380486
Drug: Lipid infusion
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid infusion (LIP)
Trial: 16380486
Drug: Control (CON)
RxNorm normalized name: Afeditab CR
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control (CON) without lipid infusion
Trial: 12760698
Drug: Dyract Flow
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dyract Flow (Dentsply DeTrey) with acid etching and/or bonding agent
Trial: 10790815
Drug: 0.05% tretinoin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05% tretinoin cream (Retinova)
Trial: 1429786
Drug: Marshall‐MacIntosh technique
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marshall‐MacIntosh technique with Kennedy ligament‐augmentation device
Trial: 3841005
Drug: BRL 20627
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BRL 20627 (10 mg i.v.)
Trial: 3841005
Drug: Zetidoline (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zetidoline (20 mg orally)
Trial: 3841005
Drug: BK 34/530
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BK 34/530 (50 mg orally)
Trial: 3841005
Drug: BK 34/530
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BK 34/530 (100 mg orally)
Trial: 30585498
Drug: Focused extracorporeal
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Focused extracorporeal shock wave therapy (f‐ESWT)
Trial: 25790903
Drug: Symptoms of
RxNorm normalized name: Pamprin Multi-Symptom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Symptoms of psychopathology, experience with tablet technology, or difficulties operating the device
Trial: 24325052
Drug: Thread-moxa in
RxNorm normalized name: Moxatag
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thread-moxa in Zhuang folk medicine combined with acupuncture and Jingwanhong Scald Ointment
Trial: 24325052
Drug: Famciclovir Tablet,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famciclovir Tablet, nimesulide dispersible tablet, vitamin B1, ribavirin ointment (Control)
Trial: 17487211
Drug: Plant sterol-enriched
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plant sterol-enriched margarine (2.5 g/day)
Trial: 17487211
Drug: Stanol-enriched margarine
RxNorm normalized name: plant stanol ester
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stanol-enriched margarine (2.5 g/day)
Trial: 17241586
Drug: Intralesional injections
RxNorm normalized name: flumethasone
DrugBank: Flumethasone (DB00663)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional injections of bleomycin with electroporation (EP)
Trial: 17241586
Drug: Intralesional injections
RxNorm normalized name: flumethasone
DrugBank: Flumethasone (DB00663)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional injections of bleomycin alone
Trial: 15229960
Drug: Naproxen sodium
RxNorm normalized name: Naproxen Sodium
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naproxen sodium 660 mg
Trial: 15229960
Drug: Ibuprofen 1200
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen 1200 mg
Trial: 15229960
Drug: Naproxen sodium
RxNorm normalized name: Naproxen Sodium
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naproxen sodium 440 mg (subgroup aged > or = 65 years)
Trial: 15229960
Drug: Ibuprofen 1200
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen 1200 mg (subgroup aged > or = 65 years)
Trial: 15229960
Drug: Naproxen sodium
RxNorm normalized name: Naproxen Sodium
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naproxen sodium 440/660 mg
Trial: 11194534
Drug: Continuous gastric
RxNorm normalized name: gastric mucins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous gastric infusion (CGI)
Trial: 9113631
Drug: Dietary Arachidonic
RxNorm normalized name: arachidonate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary Arachidonic Acid (1.7 g/d for 50 days)
Trial: 9113631
Drug: Control Diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control Diet (210 mg/d of Arachidonic Acid)
Trial: 8471596
Drug: Adoptive chemoimmunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adoptive chemoimmunotherapy (ACIT) using autolymphocyte therapy (ALT) and cyclophosphamide
Trial: 30921345
Drug: Two-day split
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-day split dose regimen
Trial: 30921345
Drug: One-day split
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One-day split dose regimen
Trial: 17684801
Drug: Atorvastatine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatine treatment for 21 days
Trial: 17684801
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (basis therapy only)
Trial: 10204900
Drug: 6 mg
RxNorm normalized name: boron 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg morphine diluted in 100 mL 0.9% normal saline (NS) and placebo intramuscular (i.m.) (peripheral MS group)
Trial: 10204900
Drug: 100 mL
RxNorm normalized name: PVC IV Bag 100 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mL of 0.9% NS alone and placebo i.m. (placebo group)
Trial: 10204900
Drug: 100 mL
RxNorm normalized name: PVC IV Bag 100 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mL of 0.9% NS and 6 mg morphine i.m. in the deltoid muscle (i.m. MS group)
Trial: 8657439
Drug: Regional intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regional intravenous guanethidine blockade (RGB)
Trial: 8657439
Drug: Placebo (tourniquet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (tourniquet inflation and i.v. injection of saline)
Trial: 2187006
Drug: Calcium dobesilate
RxNorm normalized name: CALCIUM DOBESILATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium dobesilate (1000 mg twice daily)
Trial: 382151
Drug: Domperidone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone (10 mg orally t.d.s. before meals)
Trial: 31913228
Drug: TX-001HR (17β-estradiol/progesterone)
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: TX-001HR (17β-estradiol/progesterone) at various doses (1/100, 0.5/100, 0.5/50, or 0.25/50)
Trial: 30829213
Drug: Mukalbion poly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mukalbion poly herbal chewable tablets
Trial: 25172115
Drug: Desmopressin (medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desmopressin (medication used to treat nocturia)
Trial: 22809601
Drug: Oral ibuprofen
RxNorm normalized name: ibuprofen Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ibuprofen (10 mg/kg followed by 5 mg/kg at 24 hours and 48 hours)
Trial: 22809601
Drug: Placebo (normal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (normal saline at 1 mL/kg followed by 0.5 mL/kg at 24 hours and 48 hours)
Trial: 19237683
Drug: Simplified treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simplified treatment algorithm (initial therapy with low-dose ACE inhibitor/diuretic or ARB/diuretic combination, up-titration to highest dose, addition of calcium channel blocker, addition of non-first-line antihypertensive agent)
Trial: 19237683
Drug: Simplified treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simplified treatment algorithm
Trial: 17573877
Drug: Ketoconazole 2%
RxNorm normalized name: KETOCONAZOLE 2% CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoconazole 2% cream without occlusion (group I)
Trial: 17573877
Drug: Ketoconazole 2%
RxNorm normalized name: KETOCONAZOLE 2% CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoconazole 2% cream with occlusion (group II)
Trial: 17573877
Drug: Oxiconazole 1%
RxNorm normalized name: OXICONAZOLE 1% CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxiconazole 1% cream without occlusion (group III)
Trial: 17573877
Drug: Oxiconazole 1%
RxNorm normalized name: OXICONAZOLE 1% CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxiconazole 1% cream with occlusion (group IV)
Trial: 17573877
Drug: Overall treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall treatment approach
Trial: 17573877
Drug: Surgical nail
RxNorm normalized name: FUNGI NAIL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical nail avulsion with topical antifungal agents
Trial: 15068402
Drug: Theophylline (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline (4 mg/kg/day for under 12 years, 3 mg/kg/day for over 12 years)
Trial: 8541278
Drug: Fish-oil capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish-oil capsules (2.7 g n‐3 polyunsaturated fatty acids/d)
Trial: 8541278
Drug: Olive-oil capsules
RxNorm normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olive-oil capsules (4 g/d)
Trial: 611326
Drug: Astrand‐Ryhming Test
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Astrand‐Ryhming Test administered at 50 rpm
Trial: 611326
Drug: Astrand‐Ryhming Test
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Astrand‐Ryhming Test administered at 80 rpm
Trial: 21995388
Drug: MF59-adjuvant vaccine
RxNorm normalized name: respiratory syncytial virus pre-fusion F protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MF59-adjuvant vaccine (ATIV)
Trial: 21995388
Drug: Trivalent inactivated
RxNorm normalized name: diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Tdvax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trivalent inactivated influenza vaccine without adjuvant (TIV)